Drugs May Cost Too Much, But Patents Are Not the Cause | McDonnell Boehnen Hulbert & Berghoff LLP
For at least a decade, Congress has been concerned (not to say obsessed) with drug costs (understandably so, no matter how ineffective; see "FTC to the Rescue Regarding High Drug Prices...
Source: jdsupra.com